Company Announcements

Horizon Discovery in October signed an in-licensing and option agreement with Servier for novel kinase inhibitors. Horizon will use its platform to identify the populations of cancer patients most likely to respond to the in-licensed compounds.

BIOKÉ signed an exclusive agreement to distribute Horizon Discovery’s HDx Reference Standards in the Netherlands.

For the year ending July 31, Enzo Biochem Life Sciences (LS) sales declined 8.2% to $34.2 million to account for 35% of revenues (see IBO 10/15/15). The decline was due to a 43.4% drop in royalty revenues and currency headwinds. Product sales were roughly flat excluding currency to account for 93% of LS revenue. LS adjusted operating loss slumped 30.4% to $4.4 million.

BioTime named COO Adi Mohanty as co-CEO in October.

Sigma-Aldrich entered into an exclusive agreement to manufacture and distribute the Wellcome Trust Sanger Institute’s arrayed lentiviral CRISPR library, which provides researchers with a collection of individual clones designed to knock out every known human and mouse protein coding gene using the CRISPR system.

MaxCyte named Spinco Biotech as an Indian distributor of its transfection systems.

Anteo Diagnostics named KomaBiotech as a South Korean distributor for its Anteo Mix&Go–branded products.

Product Introductions

Altogen Biosystems launched in October the PEG-Liposome In Vivo Transfection Kit, optimized for gene silencing studies and RNAi induction by delivery of functional small RNA molecules into tissues.

Affymetrix released Axiom HLA Analysis software for HLA typing from any genotyping dataset containing coverage of the extended MHC region.

Olink Bioscience introduced the Proseek Multiplex CVD II and CVD III protein biomarker panels for cardiovascular diseases, doubling the number of CDV-associated biomarkers that can be assayed to 184.

Abcam released its anti-PD-L 1 primary antibody (clone 28-8) for cancer immunology research.

Diagenode introduced its Chromatin Assembly Kit as well as a number of recombinant human histones to study specific histone modifications, as well as native and recombinant nucleosomes.

Gyros introduced four new Gyrolab CHO-HCP Kits 2-5 and two Gyrolab Human IgG Titer Kits for rapid quantification of IgG in bioprocess workflows.

Irvine Scientific released the chemically defined BalanCD Transfectory CHO cell culture medium.

Neogen introduced the Veratox for Total Aflaxtoxin ELISA, featuring a water-based solution for extraction.